Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 CAD | 0.00% | 0.00% | -8.11% |
Mar. 15 | NeuPath Health Narrows Q4 Loss, Revenue Rises | MT |
Mar. 15 | NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 62.65M 45.62M | Sales 2023 | 66.1M 48.14M | Capitalization | 10.41M 7.58M |
---|---|---|---|---|---|
Net income 2022 | -4M -2.91M | Net income 2023 | - 0 | EV / Sales 2022 | 0.35 x |
Net Debt 2022 | 12.65M 9.21M | Net Debt 2023 | 8.94M 6.51M | EV / Sales 2023 | 0.29 x |
P/E ratio 2022 |
-2.09
x | P/E ratio 2023 |
-95.3
x | Employees | 156 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.12% |
1 month | -2.86% | ||
6 months | +9.68% | ||
Current year | -8.11% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Walewicz
CEO | Chief Executive Officer | 55 | 20-06-24 |
Danish Baig
DFI | Director of Finance/CFO | - | 23-04-30 |
Jeff Zygouras
DFI | Director of Finance/CFO | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Walewicz
CEO | Chief Executive Officer | 55 | 20-06-24 |
Daniel Chicoine
CHM | Chairman | 70 | 20-06-24 |
Sasha Cucuz
BRD | Director/Board Member | 46 | 20-06-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.17 | 0.00% | 23,700 |
24-05-07 | 0.17 | -5.56% | 161,000 |
24-05-06 | 0.18 | +2.86% | 39,000 |
24-05-03 | 0.175 | +2.94% | 192,000 |
24-05-02 | 0.17 | 0.00% | 8,500 |
Delayed Quote Toronto S.E., May 08, 2024 at 03:59 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.11% | 6.97M | |
+14.31% | 81.04B | |
-30.46% | 68.93B | |
+9.93% | 29.59B | |
+0.04% | 17.24B | |
-11.30% | 16.99B | |
-1.26% | 15.12B | |
+2.64% | 13.09B | |
+62.55% | 12B | |
+29.68% | 11.91B |
- Stock Market
- Equities
- NPTH Stock